tert-Butyl N-[(1S)-3-oxocyclohexyl]carbamate, 97%, 25g

Di-n-Butylammonium tetrafluoroborate, 1g

8-METHOXYISOQUINOLIN-5-AMINE, 95%, 250mg

2-Ethynyloxetane, 98%, 500mg

5-Bromo-2,3,3-trimethyl-3H-pyrrolo[2,3-b]pyridine, 97.0%, 5g

1H-Pyrrolo[3,2-c]pyridine-4-carboxylic acid, 97%, 100mg

2-Chloroadenosine hemihydrate, 10g

Objectif à contraste de phase Plan PLPH 20x/0,40

2-Bromo-m-xylene>98.0%(GC)25g

6'-BROMOSPIRO[CYCLOBUTANE-1,3'-INDOLIN]-2'-ONE, 95.0%, 250mg

2-(Vinylsulfonyl)benzonitrile, 95%, 100mg

2-(Chloromethyl)-3,4-dimethoxypyridinehydrochloride, 95.0%, 25g

1-(4-Aminobutyl)guanidine sulfate, 95.0%, 250mg